PLXP - PLx Pharma Inc.
Previous close
0.087
0 0%
Share volume: 50,382,179
Last Updated: Wed 12 Apr 2023 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.00%
Summary score
34%
Profitability
18%
Dept financing
20%
Liquidity
45%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-239.84%
Return on assets
-16.19%
Return on sales
-8529.75%
Return on invested capital
-356.87%
Total debt ratio
62.41%
Debt ratio change over timeo
-1.3%
Current Ratio
8.89%
Quick Ratio
8.76%
Cash Position Ratio
7.82%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-55.04%
Return on assets
-19.58%
Return on sales
-12334.99%
Return on invested capital
135%
Total debt ratio
81.57%
Debt ratio change over timeo
-1.63%
Current Ratio
2.46%
Quick Ratio
2.63%
Cash Position Ratio
2.4%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-119.82%
Return on assets
-20.11%
Return on sales
0%
Return on invested capital
518.82%
Total debt ratio
71.8%
Debt ratio change over time
-2.21%
Current Ratio
2.66%
Quick Ratio
2.63%
Cash Position Ratio
2.56%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-54.73%
Return on assets
-94.15%
Return on sales
11556.01%
Return on invested capital
44.33%
Total debt ratio
-129.82%
Debt ratio change over time
-1.3%
Current Ratio
-2.64%
Quick Ratio
-8.41%
Cash Position Ratio
-2.55%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PLXP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -239.84% | 0% | 0% | 29.06% |
| Return on assets | -16.19% | 0% | 0% | -9.75% |
| Return on sales | -8529.75% | 0% | 0% | -1469.44% |
| Return on invested capital | -356.87% | 0% | 0% | 47.78% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 62.41% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.3% | 0% | 0% | 19.02% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 2.46% | 0% | 0% | 5.9% |
| Quick Ratio | 2.63% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.4% | 0% | 0% | 5.68% |
| Liquididy | 75% | 0% | 0% | 38% |
| Short-term ratios | PLXP | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -55.04% | 0% | 0% | -16.12% |
| Return on assets | -19.58% | 0% | 0% | -14.95% |
| Return on sales | -12334.99% | 0% | 0% | -3498.94% |
| Return on invested capital | 135% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 75% | 18% |
| Total debt ratio | 81.57% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.63% | 0% | 0% | 0.09% |
| Dept financing | 25% | 0% | 0% | 49% |
| Current Ratio | 2.46% | 0% | 0% | 5.9% |
| Quick Ratio | 2.63% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.4% | 0% | 0% | 5.68% |
| Liquididy | 32% | 0% | 0% | 75% |